Cryoport Inc. has signed a strategic agreement with virtual biobank, Tissue Solutions, to transport its human bio specimens to over 100 companies in the pharmaceutical and biotech industry.

Tissue Solution will use Cryport’s logistics management platform, Cryoport Express® dry vapour dewars and advanced Smart Pak IITM conditioning monitoring systems to ship isolated human cells and cryopreserved cell lines to customers across the globe.

The SmartPak system works in tandem with Cryoport’s data management platform, the CryoportalTM, to provide automated alerts on changes in transit conditions and potential temperature fluctuations.

Jerrell Shelton, CEO of California–based business Cryoport, explained, “Tissue Solutions depends on the support that only Cryoport can bring in supporting its highly successful services with Cryoport’s advanced cryogenic logistics expertise and technology, including our highly engineered and validated cryogenic cold chain shippers accompanied by crucial real-time and archived information.”